$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Genome-wide association studies (GWAS) have driven the discovery of novel candidate genes that are associated with brain pathologies1,2,3,4. These studies have been particularly beneficial in understanding devastating neuropsychiatric disorders such as schizophrenia (SCZ), where the investigation of novel genes has served as a launching point for new lines of research and therapeutic intervention5,6. Genes harboring risk for SCZ show biased expression in the prefrontal cortex (PFC) during prenatal and early postnatal development, a region implicated in the pathology of several neuropsychiatric disorders7. Additionally, mouse models of psychiatric disorders exhibit abnormal activity in PFC networks6,8,9. These results suggest that SZC-associated genes might play a role in the developmental wiring of this region. Further investigation using animal models is required to understand the contribution of these candidate genes to the establishment of connections in the PFC and to determine whether these genes have a causative role in the pathogenesis of neuropsychiatric disorders. Genetic manipulation techniques in mice that allow for the study of gene expression changes on specific neuronal circuits during prenatal and early postnatal development are a promising method to understand the molecular mechanisms that link gene expression changes to PFC dysfunction.
Genetic mouse lines offer a method to study the impact of particular genes on brain development and function. However, relying on transgenic mice can be limiting since there are not always commercially available lines to examine the effects of specific genes on developing neural circuits. Moreover, it can be extremely costly and time consuming to develop custom mouse lines. The use of intersectional genetic manipulation strategies that combine transgenic mice with viral approaches has revolutionized the understanding of the brain10,11,12. Despite much progress, viral strategies come with certain limitations depending on the viral vector type, including limits in packaging capacity that can restrict viral expression13 and cell toxicity associated with viral expression14. Furthermore, in most experimental conditions, robust gene expression using adeno-associated virus (AAVs) requires approximately 2 to 4 weeks15, making routine viral strategies unfeasible to manipulate genes during early postnatal development.
In utero electroporation (IUE) is an alternative approach that allows for a rapid and inexpensive gene transfer16,17 that, when coupled with fluorescent labeling and pharmacogenetic or optogenetic approaches, provides a powerful platform to dissect the function of neuronal circuits. Additionally, with the development of CRISPR-Cas9 genome editing genes can be overexpressed or precisely altered through cell-type specific knock-down or knock-out of specific genes or through the modulation of promoters18,19. Gene manipulation approaches using IUE are especially advantageous when the effect of genes on neuronal circuits need to be tested during narrow developmental windows20. IUE is a versatile technique and overexpression can be easily accomplished by inserting a gene into an expression vector under a specific promoter. Additional control of gene expression can be achieved by driving expression using promoters of different strengths or using inducible promoters capable of temporally controlling gene expression21,22. Additionally, IUE allows for the targeting of cells within specific cortical layers, cell types and brain regions, which isn’t always feasible using other approaches5,17. Recent advances in the IUE configuration based on the use of three electrodes, which generates a more efficient electric-field distribution, have expanded the functional repertoire of this method and allowed scientists to target new cell types and increase the efficiency, accuracy, and number of cells that can be targeted23,24. This technique was recently used to determine the causative role of complement component 4A (C4A), a gene linked to SCZ, in PFC function and early cognition5.
Presented here is an experimental pipeline that combines gene transfer approaches to target large populations of excitatory neurons in the frontal cortex, including the PFC, with behavioral paradigms that not only enables the study of cell and circuit-level changes, but also allows behavior to be monitored throughout early postnatal development and adulthood. First described is a method to bilaterally transfect large populations of layer (L) 2/3 pyramidal neurons in frontal cortical regions. Next, tasks to assay social behavior in juvenile and adult mice are outlined. Cell counts can be obtained upon the completion of behavioral tasks to quantify the extent and location of cell transfection. Furthermore, the number of cells transfected can be correlated with behavioral data to determine if a greater number of transfected cells leads to greater perturbations in behavior.